IgM anti-ApoA-I251–262 HNE levels in CAD patients with 30%~70% stenosis (1.42-fold, p = 0.0056) and >70% stenosis (1.69-fold, p = 0.0002) were significantly lower than levels in HCs (Figure 3C, right panel). The gene discussed is APOA1; the disease is coronary artery disorder.